Skip to main content
Fig. 2 | Genes and Environment

Fig. 2

From: MicroRNA miR-627-5p restrains pulmonary artery smooth muscle cell dysfunction by targeting MAP 2 K4 and PI3K/AKT signaling

Fig. 2

The influence of miR-627-5p on proliferation and migration of CSE-treated PASMCs. A qRT-PCR analysis of miR-627-5p level in PASMCs after overexpressing miR-627-5p. B CCK-8 assay of CSE-treated PASMC viability after miR-627-5p overexpression. C The detection of the lactate dehydrogenase (LDH) release of CSE-treated PASMCs after overexpressing miR-627-5p by using an LDH Cytotoxicity Assay Kit. D The images of PASMCs after different treatment under a light microscopy. E PASMC number in different groups were counted with a hemocytometer. F-G Transwell assay of PASMCs migration in each group. *p<0.05, **p<0.01, ***p<0.001

Back to article page